Osmotica Pharmaceutical Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Osmotica Pharmaceutical Corp (Osmotica) is a pharmaceutical company that specializes in drug delivery technologies and neurology based therapies. The company provides product portfolio such as nifedipine, oxybutynin, venlafaxine and desvenlafaxine, among others. It offers capabilities such as formulation research and development, analytical development, bioanalytical development, clinical development and laser drilling technologies, among others. Osmotica primarily provides development of therapies for the treatment of central nervous system (CNS) disorders. The company provides portfolio of products which are in various stages of development focused on the treatment of movement disorders. It also has operational presence in Argentina and Hungary. Osmotica is headquartered in Marietta, Georgia, the US.

Osmotica Pharmaceutical Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 11
Partnerships 13
Pernix Therapeutics Enters Into Co-Promotion Agreement With Osmotica Pharma For Khedezla ER Tablets 13
Vertcal Pharma Enters Into Co-Promotion Agreement With Poly Pharma For Zonatuss 14
Nautilus Neurosciences Enters Into Co-Promotion Agreement With Vertical Pharma For Lorzone 15
Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 16
Licensing Agreements 17
Osmotica Pharma Enters into Licensing Agreement with RevitaLid 17
Equity Offering 18
Osmotica Pharma to Raise up to USD132.8 Million in IPO of Shares 18
Acquisition 19
Jubilant Acquires Remaining 17.6% Stake in Cadista for up to USD33.2 Million in Tender Offer 19
Osmotica Pharmaceutical Corp - Key Competitors 20
Osmotica Pharmaceutical Corp - Key Employees 21
Osmotica Pharmaceutical Corp - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List Of Tables


Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Key Facts 2
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osmotica Pharmaceutical Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 11
Pernix Therapeutics Enters Into Co-Promotion Agreement With Osmotica Pharma For Khedezla ER Tablets 13
Vertcal Pharma Enters Into Co-Promotion Agreement With Poly Pharma For Zonatuss 14
Nautilus Neurosciences Enters Into Co-Promotion Agreement With Vertical Pharma For Lorzone 15
Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 16
Osmotica Pharma Enters into Licensing Agreement with RevitaLid 17
Osmotica Pharma to Raise up to USD132.8 Million in IPO of Shares 18
Jubilant Acquires Remaining 17.6% Stake in Cadista for up to USD33.2 Million in Tender Offer 19
Osmotica Pharmaceutical Corp, Key Competitors 20
Osmotica Pharmaceutical Corp, Key Employees 21
Osmotica Pharmaceutical Corp, Other Locations 22
Osmotica Pharmaceutical Corp, Subsidiaries 22
Osmotica Pharmaceutical Corp, Joint Venture 23

List Of Figures


Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9

Osmotica Pharmaceutical Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Osmotica Pharmaceutical Corp (Osmotica) is a pharmaceutical company that specializes in drug delivery technologies and neurology based therapies. The company provides product portfolio such as nifedipine, oxybutynin, venlafaxine and desvenlafaxine,

USD 250 View Report

Chong Kun Dang Pharmaceutical Corp (185750) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available